Phase
Condition
Sinusitis
Macular Degeneration
Treatment
sinusitis screening consultation
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 years
Patient followed and treated for at least 2 years for bilateral neovascular form ofage-related macular degeneration (AMD)
At least one eye treated with ≥ 6 intravitreal injections during the year precedingpreinclusion
Express consent to participate in the study
Affiliated with or beneficiary of a social security plan
Exclusion
Exclusion Criteria:
Persons referred to in articles L1121-5 to L1121-8 of the CSP (corresponding to allprotected persons: pregnant women, parturients, nursing mothers, persons deprived ofliberty by judicial or administrative decision, minors, and persons under legalprotection: guardianship or curatorship).
Severe myopia (> 6 diopters)
Patient already being treated for acute or chronic sinusitis
History of central serous chorioretinopathy or diffuse retinal epitheliopathy
Study Design
Connect with a study center
Hôpital Fondation A. de Rothschild
Paris, 75019
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.